chromium has been researched along with Granulocytic Leukemia, Chronic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beekman, JM; de Rijke, B; de Witte, T; Dolstra, H; Kester, M; Leppert, M; Maas, F; Otterud, B; Schattenberg, AV; van de Wiel-van Kemenade, E; van Horssen-Zoetbrood, A; Woestenenk, R | 1 |
1 other study(ies) available for chromium and Granulocytic Leukemia, Chronic
Article | Year |
---|---|
A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia.
Topics: Adult; Amino Acid Sequence; Antigens, CD34; Base Sequence; Bone Marrow Cells; CD8-Positive T-Lymphocytes; Cell Line; Cells, Cultured; Chromium; Chromosome Mapping; Chromosomes, Human, Pair 17; DNA-Binding Proteins; Epitopes; Female; Frameshift Mutation; Fusion Proteins, bcr-abl; Genetic Linkage; Genetic Markers; Genotype; Graft vs Leukemia Effect; Haplotypes; HLA-B Antigens; HLA-B7 Antigen; Homozygote; Humans; Interferon-gamma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Common Antigens; Lod Score; Male; Models, Genetic; Molecular Sequence Data; Neurons; Pedigree; Peptides; Plasmids; Polymorphism, Genetic; Receptors, Purinergic P2; Receptors, Purinergic P2X5; Recurrence; Retroviridae; Reverse Transcriptase Polymerase Chain Reaction; Stem Cell Transplantation; Stem Cells; T-Lymphocytes; T-Lymphocytes, Cytotoxic; Time Factors; Transcription Factors; Transplantation, Homologous | 2005 |